Related Experiment Video
Updated: Jul 10, 2026

Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue
Published on: January 6, 2012
Agents blocking the nuclear factor-kappaB pathway are effective inhibitors of endometriosis in an in vivo
Reinaldo González-Ramos1, Anne Van Langendonckt, Sylvie Defrère
1Department of Gynecology, Université Catholique de Louvain, Brussels, Belgium.
Background:
In vitro studies suggest that the transcription factor nuclear factor-kappa B (NF-kappaB) is implicated in the transduction of proinflammatory signals in endometriosis. The aim of this study was to investigate the involvement of NF-kappaB and the processes regulated by NF-kappaB in the initial development of endometriotic lesionsin vivo.
Methods:
Endometriosis was induced in nude mice by intraperitoneal injection of fluorescent-labeled menstrual endometrium. Two NF-kappaB inhibitors (BAY 11-7085 and SN-50) were injected intraperitoneally on days 0, 2 and 4 after endometriosis induction, and endometriotic lesions were recovered on day 5. Number, mass, fluorimetry and surface (morphometry) of endometriotic lesions were quantified. NF-kappaB activation, intercellular adhesion molecule (ICAM)-1 expression, cell proliferation and apoptosis were evaluated by immunohistochemical analyses and the TUNEL method.
Results:
Both NF-kappaB inhibitors induced a significant reduction in lesion development compared to control mice. NF-kappaB activation and ICAM-1 expression of endometriotic lesions were significantly reduced in treated mice, and cell proliferation was significantly reduced in BAY 11-7085-treated mice. Both inhibitors produced a significant increase in apoptosis of endometriotic lesions, as assessed by active caspase-3 immunostaining and the TUNEL method.
Conclusion:
This study demonstrates, for the first time, that the NF-kappaB pathway is implicated in the development of endometriotic lesions in vivo and that NF-kappaB inhibition reduces ICAM-1 expression and cell proliferation, but increases apoptosis of endometriotic lesions, diminishing the initial development of endometriosis in an animal model.
Insights
Inhibition of nuclear factor-kappa B (NF-kappaB) in an animal model reduced endometriosis lesion development by decreasing inflammation and cell growth while increasing cell death.
Area of Science:
- Reproductive Biology
- Molecular Biology
- Pathology
Background:
- In vitro studies implicate nuclear factor-kappa B (NF-kappaB) in inflammatory signaling in endometriosis.
- The role of NF-kappaB in the in vivo development of endometriotic lesions requires investigation.
Purpose of the Study:
- To investigate the involvement of NF-kappaB in the initial development of endometriotic lesions in vivo.
- To determine the effect of NF-kappaB inhibition on lesion growth and associated molecular processes.
Main Methods:
- Endometriosis was induced in nude mice using fluorescent-labeled menstrual endometrium.
- Mice received NF-kappaB inhibitors (BAY 11-7085, SN-50) or vehicle control.
- Lesion development, NF-kappaB activation, ICAM-1 expression, proliferation, and apoptosis were quantified.
Main Results:
- NF-kappaB inhibitors significantly reduced endometriotic lesion development.
- Inhibitors decreased NF-kappaB activation and intercellular adhesion molecule (ICAM)-1 expression.
- Cell proliferation was reduced, while apoptosis was significantly increased in endometriotic lesions.
Conclusions:
- The NF-kappaB pathway is crucial for endometriotic lesion development in vivo.
- NF-kappaB inhibition diminishes endometriosis progression by modulating inflammation, proliferation, and apoptosis.
- Targeting NF-kappaB presents a potential therapeutic strategy for endometriosis.
Related Concept Videos
Inhibition of Cdk Activity
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway

